The Recall Desk
Agency classClass IIOur severity:ModerateFDA (Drugs)·D-0486-2017·Announced 2017-03-01

Cherry Hill Sales Recalls MakeSense Antifungal Cream Due to CGMP Deviations

Cherry Hill Sales Co. is voluntarily recalling 2,400 cartons of MakeSense PHARMA ANTIFUNGAL CREAM due to Current Good Manufacturing Practice (CGMP) deviations.

The agency’s classification

FDA (Drugs): Class II

Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.

This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work

What this means for you

Our assessment, not the agency’s: severity 2/5 (Moderate).

Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.

Our severity reasoning: The recall is classified as FDA Class II, which typically corresponds to a moderate severity where adverse health consequences are temporary or medically reversible. The source text does not report any specific illnesses or injuries, and the hazard is related to manufacturing deviations rather than a specific high-risk pathogen or structural defect.

Plain-English summary

Cherry Hill Sales Co. has voluntarily initiated a recall of 2,400 cartons of MakeSense PHARMA ANTIFUNGAL CREAM 1 oz. Miconazole Nitrate 2%. The product is distributed in 1 oz. (28 g) tubes and is manufactured in China. The recall was initiated on January 27, 2017, and was terminated on April 19, 2017.

The reason for the recall is Current Good Manufacturing Practice (CGMP) deviations. The FDA classified this recall as Class II, which indicates a situation where use of, or exposure to, the violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.

The affected product is identified by NDC 69020-208-28 and UPC 857181005092. Specific lots involved are Lot #103810 with an expiration date of 09/17 and Lot #105303 with an expiration date of 04/18. The product was distributed in Michigan, Illinois, New York, Florida, and Pennsylvania. Consumers should check their inventory for these specific lot numbers and expiration dates.

The recalled product

Product
MakeSense PHARMA ANTIFUNGAL CREAM 1 oz. Miconazole Nitrate 2%, 1 oz. (28 g) tube, Made in China, Distributed by Cherry Hill Associates, Chesapeake, VA 23320, NDC 69020-208-28
Manufacturer
Cherry Hill Sales Co.
Category
Drug — Topical Antifungal
Hazard
Affected units
2,400

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (3)

  • Lot #103810
  • Exp. 09/17 Lot #105303
  • Exp. 04/18 NDC 69020-208-28 UPC 857181005092

Distribution

Distributed in 5 states:

Part of a larger recall action

This product is one of 5 recalled by Cherry Hill Sales Co. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.

See all 5 products in this recall →

Related recalls

Same manufacturer · Cherry Hill Sales Co.

See all →

Same hazard · cgmp deviations

See all →

Similar recalls